SAFE Drugs Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, SAFE Drugs Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Transportation.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H2168766390B64500B0D0CA5C1822CC2D: 1. Short title This Act may be cited as the Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026 or the SAFE Drugs Act of 2026.
- Section HF93C209B93EA410EA5F3076B91EFBF91: 2. Definitions relating to compounding of drug products Section 503A(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a(b)) is amended— by amending...
- Section HE3F1BA41274C485F99C5E4DCE73940A5: 3. Reporting requirement Section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a) is amended— by redesignating subsections (d) and (e) as...
- Section H916E623DDCF74D8DA2C3A71DBECE6231: 4. Large-scale outsourcing facilities Section 503B(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353b(b)) is amended by adding at the end the...
- Section HD7D64847EC474B5390269529D353C046: 5. Base establishment fee Section 744K(c)(1)(A)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–62(c)(1)(A)(i)) is amended by striking $15,000...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, SAFE Drugs Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Agriculture, Transportation
Primary Purpose
This bill, SAFE Drugs Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Jim Banks
R-IN | Primary Sponsor
Legislative Progress
In CommitteeRead twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Banks (for himself and Mr. Heinrich) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
Key Definitions
Terms defined in this bill
any drug product— that contains any active ingredient found in a commercially available drug product
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology